News

Oncolytics has completed an initial 100-litre production run of REOLYSIN under cGMP conditions with the support of its contract manufacturer, SAFC Pharma. The company is now preparing for

Terms of the agreement stipulate that neither party will sue each other in the field of coronary stent and stent delivery systems for a period of at least

Teleflex Incorporated has reported a decrease in revenues from continuing operations by 14% to $483.1 million in the second quarter of 2009, as compared to $559.7 million in

SuperGen has reported a net loss $2.4 million for the second quarter of 2009 , or $0.04 per basic and diluted share, as compared to a net loss

Taro Pharmaceutical Industries has filed a lawsuit against Synerx Pharma, DPT Laboratories, and Karalex Pharma in the United States District Court for New Jersey. The case is for

Ceragenix Pharmaceuticals has signed an exclusive distribution and supply agreement with Megapharm, an Israeli company. The deal is to commercialize EpiCeram, a topical cream for treating atopic dermatitis

Takeda has filed a New Drug Application (NDA) to the Japanese Ministry of Health, Labour and Welfare, for a fixed-dose combination tablet of Actos with sulfonylurea. The drug

Tranzyme has received FDA Fast Track status for the company’s oral gastrointestinal (GI) prokinetic drug candidate TZP-102. It is intended for the treatment of gastroparesis in diabetic patients.

Inovio’s SynCon dengue virus DNA vaccine showed neutralized antibody responses against all four distinct serotypes of dengue viruses, that are transmitted to humans by mosquitoes. The company’s scientists